Loading viewer...
investor_presentation
Format: PDF investor_presentation
Theranexus is a clinical-stage biotech company developing drug candidates for rare neurological disorders including juvenile Batten disease. The company leverages three scientific platforms—TFEB, neuronal hyperexcitability, and lysosomal diseases—along with innovative numerical methods to identify novel therapies based on pathological disease models.
investor_presentation
27 Pages
ServiceNow
First Eagle Investment Management Investor Presentation — December 2020
investor_presentationinvestor_presentation
8 Pages
First Eagle Investment Management